Epidemiological characteristics and genetic structure of linezolid-resistant Enterococcus faecalis
- PMID: 30538507
- PMCID: PMC6251436
- DOI: 10.2147/IDR.S181339
Epidemiological characteristics and genetic structure of linezolid-resistant Enterococcus faecalis
Abstract
Objectives: The aim of this study was to investigate the mechanism of linezolid resistance and evaluate the risk factors for linezolid-resistant Enterococcus faecalis (LZR-Efa) infections.
Methods: A total of 730 E. faecalis isolates were collected, and whole-genome sequencing and bioinformatics analysis were performed. Meanwhile, risk factors related to linezolid resistance were analyzed by binary logistic regression.
Results: Twenty-six LZR-Efa were isolated from various clinical samples, and 24 isolates were multidrug resistant. Four isolates were daptomycin nonsusceptible, while all LZR-Efa were susceptible to vancomycin. Thirteen different sequence types (STs) were identified, and the most prevalent type was ST16 (23.1%). The genes dfrE, lsaA, and emeA were identified in all isolates. A total of 23 E. faecalis were positive for optrA gene, and six amino acids mutations were identified among 18 LZR-Efa in OptrA. The 23S rRNA mutation was found in 16 LZR-Efa isolates. However, the presence of cfr was not identified. Furthermore, there were 41 virulence genes detected, and 10 genes (ace, bopD, cpsA, cpsB, ebpB, ebpC, efaA, fss1, fss2, and srtC) were found in all isolates. A total of nine isolates were positive for multiple virulent factors (ace, asa1, cylA, efaA, esp, and gelE). There was no difference in the number of virulence factors among different specimens (P=0.825). It is of note that all patients had not been prescribed linezolid or traveled abroad previously. Moreover, previous use of carbapenems was a risk factor for LZR-Efa infections.
Conclusion: The main trends of LZR-Efa, with lower level of resistance, were sporadic mainly in the department of surgery. optrA and 23S rRNA were the main resistance mechanisms. In addition, carbapenems use was an independent predictor of LZR-Efa infections.
Keywords: linezolid; resistance mechanism; risk factors; virulent factors.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures
Similar articles
-
Linezolid Resistance in Enterococcus faecalis Associated With Urinary Tract Infections of Patients in a Tertiary Hospitals in China: Resistance Mechanisms, Virulence, and Risk Factors.Front Public Health. 2021 Feb 5;9:570650. doi: 10.3389/fpubh.2021.570650. eCollection 2021. Front Public Health. 2021. PMID: 33614576 Free PMC article.
-
Distribution of the optrA gene in Enterococcus isolates at a tertiary care hospital in China.J Glob Antimicrob Resist. 2019 Jun;17:180-186. doi: 10.1016/j.jgar.2019.01.001. Epub 2019 Jan 11. J Glob Antimicrob Resist. 2019. PMID: 30641287
-
Resistance mechanisms of linezolid-nonsusceptible enterococci in Korea: low rate of 23S rRNA mutations in Enterococcus faecium.J Med Microbiol. 2017 Dec;66(12):1730-1735. doi: 10.1099/jmm.0.000637. Epub 2017 Nov 7. J Med Microbiol. 2017. PMID: 29111969
-
[Investigation of Antibiotic Resistance and Virulence Factors of Enterococcus faecium and Enterococcus faecalis Strains Isolated from Clinical Samples].Mikrobiyol Bul. 2020 Jan;54(1):26-39. doi: 10.5578/mb.68810. Mikrobiyol Bul. 2020. PMID: 32050876 Turkish.
-
Emergence of optrA-Mediated Linezolid-Nonsusceptible Enterococcus faecalis in a Tertiary Care Hospital.Ann Lab Med. 2020 Jul;40(4):321-325. doi: 10.3343/alm.2020.40.4.321. Ann Lab Med. 2020. PMID: 32067432 Free PMC article.
Cited by
-
Mechanisms of Linezolid Resistance Among Enterococci of Clinical Origin in Spain-Detection of optrA- and cfr(D)-Carrying E. faecalis.Microorganisms. 2020 Jul 30;8(8):1155. doi: 10.3390/microorganisms8081155. Microorganisms. 2020. PMID: 32751552 Free PMC article.
-
High occurrence of Enterococcus faecalis, Enterococcus faecium, and Vagococcus lutrae harbouring oxazolidinone resistance genes in raw meat-based diets for companion animals - a public health issue, Switzerland, September 2018 to May 2020.Euro Surveill. 2023 Feb;28(6):2200496. doi: 10.2807/1560-7917.ES.2023.28.6.2200496. Euro Surveill. 2023. PMID: 36757316 Free PMC article.
-
The Impact of Enterococcus spp. in the Immunocompromised Host: A Comprehensive Review.Pathogens. 2024 May 15;13(5):409. doi: 10.3390/pathogens13050409. Pathogens. 2024. PMID: 38787261 Free PMC article. Review.
-
Emergence of multidrug resistance and extensive drug resistance among enterococcal clinical isolates in Egypt.Infect Drug Resist. 2019 May 7;12:1113-1125. doi: 10.2147/IDR.S189341. eCollection 2019. Infect Drug Resist. 2019. PMID: 31118713 Free PMC article.
-
Genomic Insights Into Last-Line Antimicrobial Resistance in Multidrug-Resistant Staphylococcus and Vancomycin-Resistant Enterococcus.Front Microbiol. 2021 Mar 16;12:637656. doi: 10.3389/fmicb.2021.637656. eCollection 2021. Front Microbiol. 2021. PMID: 33796088 Free PMC article. Review.
References
-
- Teixeira LM, Carvalho MGS, Shewmaker PL, Facklam RR. Enterococcus. In: Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW, editors. Manual of Clinical Microbiology. 10th ed. Wahington, DC: ASM Press; 2011. p. 350e64.
-
- Mendes RE, Deshpande L, Streit JM, et al. ZAAPS programme results for 2016: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 42 countries. J Antimicrob Chemother. 2018 Apr 6; Epub. - PubMed
-
- Antimicrobial resistance surveillance in Europe. 2016. [Accessed October 26, 2018]. Available from: https://ecdc.europa.eu/en/publications-data/antimicrobial-resistance-sur....
-
- Bi R, Qin T, Fan W, Ma P, Gu B. The emerging problem of linezolid-resistant enterococci. J Glob Antimicrob Resist. 2018;13:11–19. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous